272 related articles for article (PubMed ID: 12410437)
1. [Pancreatic cancer--treatment].
Pistorius GA; Schilling MK
Dtsch Med Wochenschr; 2002 Nov; 127(44):2330-2. PubMed ID: 12410437
[No Abstract] [Full Text] [Related]
2. [Oncological surgery of the pancreas and bile ducts: current therapeutic prospects].
Silvestri A; Peparini N
G Chir; 2006; 27(11-12):401-4. PubMed ID: 17198547
[No Abstract] [Full Text] [Related]
3. [Surgical results and indications for adjuvant measures in pancreatic cancer].
Beger HG; Büchler MW; Friess H
Chirurg; 1994 Apr; 65(4):246-52. PubMed ID: 7912665
[No Abstract] [Full Text] [Related]
4. Pancreatic cancer: 1998 update.
Yeo CJ
J Am Coll Surg; 1998 Oct; 187(4):429-42. PubMed ID: 9783792
[No Abstract] [Full Text] [Related]
5. [Treatment of carcinoma of the pancreatic head].
Hopt UT
Zentralbl Chir; 2006 Apr; 131(2):115-20. PubMed ID: 16612777
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic adenocarcinoma.
Eskander MF; Bliss LA; Tseng JF
Curr Probl Surg; 2016 Mar; 53(3):107-54. PubMed ID: 26923296
[No Abstract] [Full Text] [Related]
7. Prolonged survival after resection of pancreatic cancer with a solitary hepatic metastasis.
Guillem P; Mornex F; Partensky C
Hepatogastroenterology; 2004; 51(60):1 p preceeding I. PubMed ID: 15532780
[No Abstract] [Full Text] [Related]
8. Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al.
Adams RB; Allen PJ
Ann Surg Oncol; 2009 Jul; 16(7):1745-50. PubMed ID: 19396494
[No Abstract] [Full Text] [Related]
9. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
Zhu AX; Clark JW; Willett CG
Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.
Evans DB; Farnell MB; Lillemoe KD; Vollmer C; Strasberg SM; Schulick RD
Ann Surg Oncol; 2009 Jul; 16(7):1736-44. PubMed ID: 19387741
[No Abstract] [Full Text] [Related]
12. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival (superior to 20 years) after pancreaticoduodenectomy for pancreatic duct adenocarcinoma: report of two cases.
Naseef O; Adham M; Hervieu V; Le Borgne J; Partensky C
Hepatogastroenterology; 2008; 55(84):1110-1. PubMed ID: 18705340
[TBL] [Abstract][Full Text] [Related]
14. [Ways of improving long-term results of treatment in resectable pancreatic cancer].
Patiutko IuI; Kotel'nikov AG; Badalian KhV; Sagaĭdak IV
Vopr Onkol; 1998; 44(5):628-31. PubMed ID: 9884731
[No Abstract] [Full Text] [Related]
15. The effect on prognosis of postoperative CA 19-9 level in patients with pancreatic cancer.
Kilickap S; Arslan C
Am J Clin Oncol; 2010 Jun; 33(3):320; author reply 320. PubMed ID: 20526087
[No Abstract] [Full Text] [Related]
16. Chemoradiotherapy for pancreatic cancer: current status and perspectives.
Oya N
Int J Clin Oncol; 2004 Dec; 9(6):451-7. PubMed ID: 15616875
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pancreatic adenocarcinoma: a European perspective.
Gouma DJ; Busch OR; van Gulik TM
Surg Oncol Clin N Am; 2008 Jul; 17(3):569-86, ix. PubMed ID: 18486884
[TBL] [Abstract][Full Text] [Related]
18. Extended lymphadenectomy in the surgery of pancreatic adenocarcinoma and its relation to quality improvement issues.
Rupp CC; Linehan DC
J Surg Oncol; 2009 Mar; 99(4):207-14. PubMed ID: 19072980
[TBL] [Abstract][Full Text] [Related]
19. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
20. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
White RR; Xie HB; Gottfried MR; Czito BG; Hurwitz HI; Morse MA; Blobe GC; Paulson EK; Baillie J; Branch MS; Jowell PS; Clary BM; Pappas TN; Tyler DS
Ann Surg Oncol; 2005 Mar; 12(3):214-21. PubMed ID: 15827813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
